Potassium Chloride Capsule, Extended Release
NDC Package 68462-357-05
Package Information
Potassium Chloride capsules is a medication a mineral supplement used to treat or prevent low amounts of potassium in the blood. This formulation utilizes a capsule, extended release delivery system. Marketed by Glenmark Pharmaceuticals Inc., Usa, this product is identified by NDC 68462-357 and is authorized under FDA application ANDA202868.
Identification & Billing
- RxCUI: 312504 - potassium chloride 10 MEQ Extended Release Oral Capsule
- RxCUI: 312504 - K+ Chloride 10 MEQ Extended Release Oral Capsule
- RxCUI: 312504 - Pot Chloride 10 MEQ Extended Release Oral Capsule
- RxCUI: 312504 - potassium chloride 750 MG Extended Release Oral Capsule
Clinical Specifications
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Potassium Compounds - [CS]
- Potassium Salt - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 68462 - Glenmark Pharmaceuticals Inc., Usa
- 68462-357 - Potassium Chloride
- 68462-357-05 - 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE
- 68462-357 - Potassium Chloride
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (68462-357). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 68462-357-05 identifies a specific commercial package of 500 capsule, extended release in 1 bottle of Potassium Chloride, a human prescription drug labeled by Glenmark Pharmaceuticals Inc., Usa. This capsule, extended release is formulated for oral use and contains potassium chloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Glenmark Pharmaceuticals Inc., Usa on January 20, 2016. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is a mineral supplement used to treat or prevent low amounts of potassium in the blood. A normal level of potassium in the blood is important. Potassium helps your cells, kidneys, heart, muscles, and nerves work properly. Most people get enough potassium by eating a well-balanced diet. Some conditions that can lower your body's potassium level include severe prolonged diarrhea and vomiting, hormone problems such as hyperaldosteronism, or treatment with "water pills"/diuretics.
How is this Glenmark Pharmaceuticals Inc., Usa product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 68462035705. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 500 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.